$EXFY
Expensify Inc

2024 Q3 Form 10-Q Financial Statement

#000147684024000215 Filed on November 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $35.41M $36.49M
YoY Change -2.97% -14.12%
Cost Of Revenue $17.15M $17.68M
YoY Change -3.03% 6.8%
Gross Profit $18.26M $18.81M
YoY Change -2.92% -27.47%
Gross Profit Margin 51.58% 51.55%
Selling, General & Admin $12.36M $27.11M
YoY Change -54.41% -4.02%
% of Gross Profit 67.66% 144.07%
Research & Development $5.618M $6.607M
YoY Change -14.97% 93.41%
% of Gross Profit 30.76% 35.12%
Depreciation & Amortization $100.0K $200.0K
YoY Change -50.0% -60.0%
% of Gross Profit 0.55% 1.06%
Operating Expenses $17.98M $33.71M
YoY Change -46.68% 6.49%
Operating Profit $288.0K -$14.90M
YoY Change -101.93% 160.59%
Interest Expense -$2.375M
YoY Change 0.25%
% of Operating Profit
Other Income/Expense, Net $181.0K -$2.375M
YoY Change -107.62%
Pretax Income $469.0K -$17.27M
YoY Change -102.72% 113.62%
Income Tax $2.667M -$300.0K
% Of Pretax Income 568.66%
Net Earnings -$2.198M -$17.00M
YoY Change -87.07% 106.3%
Net Earnings / Revenue -6.21% -46.59%
Basic Earnings Per Share -$0.02 -$0.21
Diluted Earnings Per Share -$0.02 -$0.21
COMMON SHARES
Basic Shares Outstanding 88.18M shares 82.47M shares
Diluted Shares Outstanding 88.18M shares 82.47M shares

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $95.80M
YoY Change -12.98%
Cash & Equivalents $39.17M $89.12M
Short-Term Investments
Other Short-Term Assets $24.32M $27.93M
YoY Change -12.93% 31.47%
Inventory
Prepaid Expenses $9.002M $5.153M
Receivables $12.65M $14.51M
Other Receivables $4.200M
Total Short-Term Assets $138.5M $179.6M
YoY Change -22.88% -4.85%
LONG-TERM ASSETS
Property, Plant & Equipment $13.76M $14.60M
YoY Change -5.72% -1.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $988.0K $789.0K
YoY Change 25.22% 36.03%
Total Long-Term Assets $37.71M $32.67M
YoY Change 15.42% 42.65%
TOTAL ASSETS
Total Short-Term Assets $138.5M $179.6M
Total Long-Term Assets $37.71M $32.67M
Total Assets $176.2M $212.3M
YoY Change -16.99% 0.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.035M $1.292M
YoY Change -19.89% -40.65%
Accrued Expenses $150.0K $155.0K
YoY Change -3.23% -22.89%
Deferred Revenue $529.0K $633.0K
YoY Change -16.43% 134.44%
Short-Term Debt $15.00M
YoY Change 0.0%
Long-Term Debt Due $0.00 $8.099M
YoY Change -100.0% 1375.23%
Total Short-Term Liabilities $48.34M $73.77M
YoY Change -34.47% 16.79%
LONG-TERM LIABILITIES
Long-Term Debt $35.58M
YoY Change -31.01%
Other Long-Term Liabilities $2.045M $1.408M
YoY Change 45.24% 22.97%
Total Long-Term Liabilities $2.045M $36.99M
YoY Change -94.47% -29.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $48.34M $73.77M
Total Long-Term Liabilities $2.045M $36.99M
Total Liabilities $56.31M $117.3M
YoY Change -51.98% 1.19%
SHAREHOLDERS EQUITY
Retained Earnings -$149.5M -$133.6M
YoY Change 11.94% 49.21%
Common Stock $9.000K $7.000K
YoY Change 28.57% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $119.9M $95.06M
YoY Change
Total Liabilities & Shareholders Equity $176.2M $212.3M
YoY Change -16.99% 0.29%

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$2.198M -$17.00M
YoY Change -87.07% 106.3%
Depreciation, Depletion And Amortization $100.0K $200.0K
YoY Change -50.0% -60.0%
Cash From Operating Activities -$5.110M
YoY Change 450.05%
INVESTING ACTIVITIES
Capital Expenditures $2.310M
YoY Change -462.07%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.310M
YoY Change 262.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 670.0K
YoY Change -121.63%
NET CHANGE
Cash From Operating Activities -5.110M
Cash From Investing Activities -2.310M
Cash From Financing Activities 670.0K
Net Change In Cash -6.750M
YoY Change 44.69%
FREE CASH FLOW
Cash From Operating Activities -$5.110M
Capital Expenditures $2.310M
Free Cash Flow -$7.420M
YoY Change 2449.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity File Number
EntityFileNumber
001-41043
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Expensify, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-0239450
dei Entity Address Address Line1
EntityAddressAddressLine1
401 SW 5th Ave
dei Entity Address City Or Town
EntityAddressCityOrTown
Portland
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
97204
dei City Area Code
CityAreaCode
971
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39172000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47510000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12650000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13834000 usd
CY2023Q4 exfy Lease Liability Non Current
LeaseLiabilityNonCurrent
6467000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2045000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1681000 usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
us-gaap Cost Of Revenue
CostOfRevenue
46091000 usd
us-gaap Cost Of Revenue
CostOfRevenue
50380000 usd
us-gaap Gross Profit
GrossProfit
56141000 usd
us-gaap Gross Profit
GrossProfit
65099000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17936000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17119000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29760000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38386000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
36757000 usd
us-gaap Operating Expenses
OperatingExpenses
57426000 usd
us-gaap Operating Expenses
OperatingExpenses
92262000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1285000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-27163000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2318000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32321000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8743000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8743000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-34252000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-34252000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Net Income Loss
NetIncomeLoss
-34252000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3871000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
476000 usd
exfy Gain Loss On Impairment Receivables And Sale Or Disposal Of Equipment
GainLossOnImpairmentReceivablesAndSaleOrDisposalOfEquipment
-585000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
30612000 usd
exfy Increase Decrease In Settlement Assets
IncreaseDecreaseInSettlementAssets
9381000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3672000 usd
exfy Payments For The Repurchases Of Early Exercised Stock Options
PaymentsForTheRepurchasesOfEarlyExercisedStockOptions
21000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3132000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
216000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1766000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10371000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13102000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85254000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
134608000 usd
us-gaap Interest Paid Net
InterestPaidNet
4396000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3104000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2219000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39172000 usd
CY2024Q3 exfy Restricted Cash Included In Settlement Assets
RestrictedCashIncludedInSettlementAssets
22334000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85254000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35409000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36494000 usd
CY2024Q3 exfy Deferred Contract Acquisition Costs
DeferredContractAcquisitionCosts
284000 usd
CY2024Q3 exfy Accrued Credit Card Processing Fees Current
AccruedCreditCardProcessingFeesCurrent
153000 usd
CY2023Q4 exfy Accrued Credit Card Processing Fees Current
AccruedCreditCardProcessingFeesCurrent
76000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7630000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10267000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2700000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-300000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-5.687
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.016
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6400000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1900000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
2.772
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.060
CY2024Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1900000 usd
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1500000 usd
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
300000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2198000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2198000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17003000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-17003000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8743000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8743000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-34252000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-34252000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88177739 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88177739 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82469190 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82469190 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2377071 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4166678 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1715576 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4673936 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001476840
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.expensify.com/20240930#RightOfUseAssets
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.expensify.com/20240930#RightOfUseAssets
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.expensify.com/20240930#RightOfUseAssets
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.expensify.com/20240930#RightOfUseAssets
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.expensify.com/20240930#LeaseLiabilityCurrent
CY2024Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.expensify.com/20240930#LeaseLiabilityCurrent
CY2024Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://www.expensify.com/20240930#LeaseLiabilityNonCurrent
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Address State Or Province
EntityAddressStateOrProvince
OR
dei Local Phone Number
LocalPhoneNumber
365-3939
dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.0001 per share
CY2023Q4 us-gaap Settlement Assets Current
SettlementAssetsCurrent
39261000 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9002000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5649000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
24321000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
30978000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
138536000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
137232000 usd
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
16859000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
12494000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13763000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14372000 usd
CY2024Q3 exfy Right Of Use Assets
RightOfUseAssets
5611000 usd
CY2023Q4 exfy Right Of Use Assets
RightOfUseAssets
6435000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
489000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
457000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
988000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5794000 usd
CY2024Q3 us-gaap Assets
Assets
176246000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7655000 usd
CY2024Q3 exfy Lease Liability Current
LeaseLiabilityCurrent
631000 usd
CY2023Q4 exfy Lease Liability Current
LeaseLiabilityCurrent
432000 usd
CY2024Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
39379000 usd
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
33990000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
48339000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
67892000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
102232000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
115479000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9730000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86643209 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86643209 shares
CY2023Q4 exfy Cash In Transit For Funds Held For Customers Current
CashInTransitForFundsHeldForCustomersCurrent
5107000 usd
CY2024Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
126000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2993000 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
2300000 usd
us-gaap Depreciation
Depreciation
600000 usd
us-gaap Depreciation
Depreciation
1100000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
159000 usd
CY2024Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
75000 usd
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
140000 usd
CY2024Q3 exfy Accrued Hosting And License Fees Current
AccruedHostingAndLicenseFeesCurrent
44000 usd
CY2023Q4 exfy Accrued Hosting And License Fees Current
AccruedHostingAndLicenseFeesCurrent
134000 usd
CY2024Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
532000 usd
CY2023Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
661000 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
7294000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
9390000 usd
CY2024Q3 exfy Number Of Operating Lease Agreements
NumberOfOperatingLeaseAgreements
0 lease
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
34000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
77000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
102000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
472000 usd
CY2024Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
6000 usd
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
3000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
19000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
7000 usd
CY2024Q3 exfy Finance Lease Cost
FinanceLeaseCost
40000 usd
CY2023Q3 exfy Finance Lease Cost
FinanceLeaseCost
80000 usd
exfy Finance Lease Cost
FinanceLeaseCost
121000 usd
exfy Finance Lease Cost
FinanceLeaseCost
479000 usd
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
270000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
277000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
805000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
707000 usd
CY2024Q3 us-gaap Lease Cost
LeaseCost
310000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
357000 usd
us-gaap Lease Cost
LeaseCost
926000 usd
us-gaap Lease Cost
LeaseCost
1186000 usd
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
261000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
364000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5350000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6071000 usd
CY2024Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y11M1D
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y6M10D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y2M4D
CY2024Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0810
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0810
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0830
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0830
us-gaap Operating Lease Payments
OperatingLeasePayments
327000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
466000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
19000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
7000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
96000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
482000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
39000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
189000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
153000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1079000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
102000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1018000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
0 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1033000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1063000 usd
CY2024Q3 exfy Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2024Q3 exfy Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
4499000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
294000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8881000 usd
CY2024Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
21000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2595000 usd
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
137000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
494000 usd
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
136000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5792000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1931000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-17003000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88177739 shares
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96658000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147710000 usd
us-gaap Interest Paid Net
InterestPaidNet
1326000 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Trading Symbol
TradingSymbol
EXFY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 us-gaap Settlement Assets Current
SettlementAssetsCurrent
53391000 usd
CY2023Q4 us-gaap Assets
Assets
176784000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1035000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1425000 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
7294000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
9390000 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
15000000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
56312000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
76040000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
9000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
8000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
269441000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
241509000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-149516000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-140773000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
100744000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176246000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176784000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35409000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36494000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8384000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2198000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
119934000 usd
dei Document Type
DocumentType
10-Q
CY2024Q3 exfy Lease Liability Non Current
LeaseLiabilityNonCurrent
5928000 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
17680000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
18264000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
18814000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5618000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6607000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9084000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14245000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12860000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
17976000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
33712000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
288000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-14898000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
469000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17273000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2667000 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88177739 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82085508 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82085508 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
114000000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
250000 usd
CY2024Q3 exfy Adjustments To Additional Paid In Capital Value Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalValueVestingOfEarlyExercisedStockOptions
94000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
18000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11087000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-17003000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
95056000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
100744000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
303000 usd
exfy Adjustments To Additional Paid In Capital Value Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalValueVestingOfEarlyExercisedStockOptions
337000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
53000 usd
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
2900000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://www.expensify.com/20240930#LeaseLiabilityNonCurrent
CY2023 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
CY2024Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
119934000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
17145000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3274000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
181000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2375000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1033000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5158000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-270000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6425000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2198000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2198000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17003000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82469190 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82469190 shares
CY2024Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
896000 usd
CY2024Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
1510000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
99863000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
91000 usd
CY2023Q3 exfy Adjustments To Additional Paid In Capital Value Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalValueVestingOfEarlyExercisedStockOptions
182000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
30000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
8000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
1056000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
242000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
1510000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25850000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8743000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
119934000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
97241000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
216000 usd
exfy Adjustments To Additional Paid In Capital Value Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalValueVestingOfEarlyExercisedStockOptions
584000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
91000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
21000 usd
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
3132000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1766000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32831000 usd
us-gaap Net Income Loss
NetIncomeLoss
-34252000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
95056000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8743000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4851000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
411000 usd
exfy Gain Loss On Impairment Receivables And Sale Or Disposal Of Equipment
GainLossOnImpairmentReceivablesAndSaleOrDisposalOfEquipment
-637000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
23535000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
43000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
139000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-32000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-86000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-845000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1671000 usd
exfy Increase Decrease In Settlement Assets
IncreaseDecreaseInSettlementAssets
13202000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1597000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-2707000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1861000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
144000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
125000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-349000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
229000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1501000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4259000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
67000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-236000 usd
exfy Increase Decrease In Settlement Liabilities
IncreaseDecreaseInSettlementLiabilities
5389000 usd
exfy Increase Decrease In Settlement Liabilities
IncreaseDecreaseInSettlementLiabilities
2451000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
364000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
78000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16475000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2102000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1103000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
6699000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
3730000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6699000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4833000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
96000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
482000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
22671000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8450000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
71000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
exfy Payments For The Repurchases Of Early Exercised Stock Options
PaymentsForTheRepurchasesOfEarlyExercisedStockOptions
35000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2900000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
303000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1510000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21180000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11404000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3735000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2315000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
178000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6402000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
409000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89118000 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
23748000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
23398000 usd
CY2023Q3 exfy Restricted Cash Included In Settlement Assets
RestrictedCashIncludedInSettlementAssets
22092000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
134608000 usd
CY2024Q3 exfy Number Of Card Programs
NumberOfCardPrograms
2 program
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Expensify Neue',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Expensify Neue',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and judgments are based on historical experience, forecasted events and various other assumptions that the Company believes to be reasonable under the circumstances. Estimates and judgments are evaluated on an ongoing basis. Actual results could differ from those estimates. Changes in estimates are recorded in the period in which they become known.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Expensify Neue',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimates and assumptions by management affect the Company’s classification of employee and employee-related expenses, the useful lives and recoverability of long-lived assets and deferred contract acquisition costs, income taxes, capitalization of internal-use software costs, stock-based compensation and the Company's incremental borrowing rate utilized to measure its lease right-of-use ("ROU") assets and lease liabilities.</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Expensify Neue',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification of Prior Period Presentation</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Expensify Neue',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of financial position, operations and cash flows.</span></div>
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
102232000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
115479000 usd
CY2024Q3 exfy Revenue From Contract With Customer Cash Rewards To Customer
RevenueFromContractWithCustomerCashRewardsToCustomer
2300000 usd
CY2023Q3 exfy Revenue From Contract With Customer Cash Rewards To Customer
RevenueFromContractWithCustomerCashRewardsToCustomer
1800000 usd
exfy Revenue From Contract With Customer Cash Rewards To Customer
RevenueFromContractWithCustomerCashRewardsToCustomer
6400000 usd
exfy Revenue From Contract With Customer Cash Rewards To Customer
RevenueFromContractWithCustomerCashRewardsToCustomer
4800000 usd
CY2024Q3 exfy Consideration From Vendors Net
ConsiderationFromVendorsNet
800000 usd
CY2023Q3 exfy Consideration From Vendors Net
ConsiderationFromVendorsNet
2800000 usd
exfy Consideration From Vendors Net
ConsiderationFromVendorsNet
7100000 usd
exfy Consideration From Vendors Net
ConsiderationFromVendorsNet
7300000 usd
CY2024Q3 exfy Card Collateral For Funds Held For Customers Current
CardCollateralForFundsHeldForCustomersCurrent
15388000 usd
CY2023Q4 exfy Card Collateral For Funds Held For Customers Current
CardCollateralForFundsHeldForCustomersCurrent
16561000 usd
CY2024Q3 exfy Earned Interchange Restricted Cash
EarnedInterchangeRestrictedCash
1486000 usd
CY2023Q4 exfy Earned Interchange Restricted Cash
EarnedInterchangeRestrictedCash
0 usd
CY2024Q3 exfy Cash In Transit For Funds Held For Customers Current
CashInTransitForFundsHeldForCustomersCurrent
775000 usd
CY2023Q4 exfy Deferred Contract Acquisition Costs
DeferredContractAcquisitionCosts
129000 usd
CY2024Q3 exfy Other Restricted Cash Current
OtherRestrictedCashCurrent
124000 usd
CY2023Q4 exfy Other Restricted Cash Current
OtherRestrictedCashCurrent
80000 usd
CY2024Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
163000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
114000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
24321000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
30978000 usd
CY2024Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
31172000 usd
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
22683000 usd
CY2024Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
14313000 usd
CY2023Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
10189000 usd
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
16859000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
12494000 usd
CY2024Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1600000 usd
CY2023Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
800000 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
4100000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23251000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23251000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9488000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8879000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13763000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14372000 usd
CY2024Q3 us-gaap Depreciation
Depreciation
100000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
200000 usd
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
2168000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2546000 usd
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1482000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1311000 usd
CY2024Q3 exfy Accrued Partner Payouts And Advertising Fees Current
AccruedPartnerPayoutsAndAdvertisingFeesCurrent
1142000 usd
CY2023Q4 exfy Accrued Partner Payouts And Advertising Fees Current
AccruedPartnerPayoutsAndAdvertisingFeesCurrent
1486000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
529000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
915000 usd
CY2024Q3 exfy Employee Stock Purchase Plan Payroll Liability
EmployeeStockPurchasePlanPayrollLiability
404000 usd
CY2023Q4 exfy Employee Stock Purchase Plan Payroll Liability
EmployeeStockPurchasePlanPayrollLiability
198000 usd
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
378000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
843000 usd
CY2024Q3 exfy Restricted Common Stock Liability For Early Stock Option Exercises Current
RestrictedCommonStockLiabilityForEarlyStockOptionExercisesCurrent
202000 usd
CY2023Q4 exfy Restricted Common Stock Liability For Early Stock Option Exercises Current
RestrictedCommonStockLiabilityForEarlyStockOptionExercisesCurrent
562000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
150000 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
35000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
359000 usd
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M1D
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
25204250 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
32.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
30.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
38.13
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.45
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5902591 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.68
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
306917 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.99
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
122788 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.12
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5472886 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.66
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y1M24D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5447146 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.65
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y1M20D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5900000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8900000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5900000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
300000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
200000 usd
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
8384000 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
11087000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
25850000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
32831000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23535000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30612000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7630000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10267000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23535000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30612000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86643209 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86643209 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82085508 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82085508 shares
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001476840-24-000215-index-headers.html Edgar Link pending
0001476840-24-000215-index.html Edgar Link pending
0001476840-24-000215.txt Edgar Link pending
0001476840-24-000215-xbrl.zip Edgar Link pending
exfy-20240930.htm Edgar Link pending
exfy-20240930.xsd Edgar Link pending
exhibit102-secondamendment.htm Edgar Link pending
exhibit31-10xqq32024.htm Edgar Link pending
exhibit311-10xqq32024.htm Edgar Link pending
exhibit312-10xqq32024.htm Edgar Link pending
exhibit321-10xqq32024.htm Edgar Link pending
exhibit322-10xqq32024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
exfy-20240930_def.xml Edgar Link unprocessable
exfy-20240930_lab.xml Edgar Link unprocessable
exfy-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
exfy-20240930_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
exfy-20240930_cal.xml Edgar Link unprocessable